Exclusive

Publication

Byline

Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate ... Read More


Atiku criticises NASS for hurried approval of Tinubu's $6bn loan requests

Nigeria, April 1 -- A former Vice President, Atiku Abubakar, has faulted the National Assembly for approving President Bola Tinubu's request to obtain two fresh foreign loans totalling $6 billion from... Read More


PM Modi chairs high-level CCS meet amid Iran-US conflict; focus on oil prices and national security

Bhubaneswar, April 1 -- PM Modi on Wednesday chaired a crucial meeting of the Cabinet Committee on Security (CCS) to assess the implications of the escalating Iran-US, Israel conflict on India's econo... Read More


Diamond Power Infrastructure gains on bagging Rs 61-cr cable order from GETCO

Mumbai, April 1 -- The order involves the supply of approximately 270 kilometers of 66 kV extra high voltage (EHV) cables, marking a significant milestone for the company and strengthening its positio... Read More


IREDA rallies after loan book climbs 22% YoY in March26

Mumbai, April 1 -- As on 31st March 2026, loan sanctioned rose 9% YoY to Rs 51,883 crore and loan disbursements climbed 16% YoY to Rs 34,946 crore. Meanwhile, the company's wholly owned subsidiary, I... Read More


Nippon India Mutual Fund announces Resignation of Fund Manager

Mumbai, April 1 -- Nippon India Mutual Fund Announces Resignation of Fund Manager that Mr. Divya Dutt Sharma, Research Associate & Assistant Fund Manager - Overseas Investment has resigned from Nippon... Read More


Clinical Trial: A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503340) titled 'A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodyna... Read More


Clinical Trial: Neuroprotection of Memantine and Rosuvastatin

U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07504198) titled 'Neuroprotection of Memantine and Rosuvastatin' on March 15. Brief Summary: Memantine is us... Read More


Clinical Trial: Fiber-Enriched, Sodium-Controlled Enteral Formula for Glycemia and Blood Pressure in Tube-Fed Residents With Diabetes

U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07504380) titled 'Fiber-Enriched, Sodium-Controlled Enteral Formula for Glycemia and Blood Pressure in Tube-F... Read More


Clinical Trial: Outcomes of Definitive Radiotherapy for Bladder Cancer

U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503795) titled 'Outcomes of Definitive Radiotherapy for Bladder Cancer' on Feb. 05. Brief Summary: this is... Read More